Literature DB >> 22925488

[Organs at risk and target volumes: definition for conformal radiation therapy in breast cancer].

I Atean1, Y Pointreau, I Barillot, Y-M Kirova.   

Abstract

Adjuvant radiotherapy is a standard component of breast cancer treatment. The addition of radiotherapy after breast conserving surgery has been shown to reduce local recurrence rate and improve long-term survival. Accurate delineation of target volumes and organs at risk is crucial to the quality of treatment planning and delivered accomplished with innovate technologies in radiation therapy. This allows the radiation beam to be shaped specifically to each individual patient's anatomy. Target volumes include the mammary gland and surgical bed in case of breast conserving surgery, the chest wall in case of mastectomy, and if indicated, regional lymph nodes (axillary, supra- and infraclavicular and internal mammary). Organs at risk include lungs, thyroid, brachial plexus, heart, spinal cord and oesophagus. The aim of this article is to encourage the use of conformal treatment and delineation of target volumes and organs at risk and to describe specifically the definition of these volumes.
Copyright © 2012 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22925488     DOI: 10.1016/j.canrad.2012.06.002

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Reliability and accuracy assessment of Radiation Therapy Oncology Group-endorsed guidelines for brachial plexus contouring.

Authors:  Joris Van de Velde; Tom Vercauteren; Werner De Gersem; Johan Wouters; Katrien Vandecasteele; Philippe Vuye; Frank Vanpachtenbeke; Katharina D'Herde; Ingrid Kerckaert; Wilfried De Neve; Tom Van Hoof
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

2.  Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy.

Authors:  Olivier Lauche; Youlia M Kirova; Pascal Fenoglietto; Emilie Costa; Claire Lemanski; Celine Bourgier; Olivier Riou; David Tiberi; Francois Campana; Alain Fourquet; David Azria
Journal:  World J Radiol       Date:  2016-08-28

3.  Helical tomotherapy for inoperable breast cancer: a new promising tool.

Authors:  Ciprian Chira; Youlia M Kirova; Xavier Liem; François Campana; Dominique Peurien; Malika Amessis; Nathalie Fournier-Bidoz; Jean-Yves Pierga; Rémi Dendale; Pierre Bey; Alain Fourquet
Journal:  Biomed Res Int       Date:  2013-09-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.